Partners Stuart Katz and Philip Richter and associate Angelique Mamby noted for representation of Goldman, Sachs & Co. as financial adviser to King Pharmaceuticals Inc. in its acquisition by Mylan Laboratories Inc., <em>New York Law Journal</em>

Partners Stuart Katz and Philip Richter and associate Angelique Mamby noted for representation of Goldman, Sachs & Co. as financial adviser to King Pharmaceuticals Inc. in its acquisition by Mylan Laboratories Inc., New York Law Journal

In the July 29th "Big Deals" column, the New York Law Journal notes that "Mylan Laboratories Inc. agreed...to acquire King Pharmaceuticals Inc. for $4 billion in a stock-for-stock transaction, which will create the second-largest pharmaceutical company in the United States based on the number of prescriptions distributed....Fried, Frank, Harris, Shriver & Jacobson [LLP] represented Goldman, Sachs & Co., the financial adviser to King Pharmaceuticals, with partners Stuart Z. Katz and Philip Richter and associate Angelique Mamby, who will become a partner on Sept. 1"

news-detail.inc